PNLIP and obesity due to melanocortin 4 receptor deficiency: It has been clinically reported that a pancreatic lipase inhibitor, orlistat, prevented obesity and hyperlipidemia through the increment of fat excretion in the feces and the inhibition of pancreatic lipase.